P05.93 Adult medulloblastoma: analysis of use of chemotherapy in clinical practice

BACKGROUND: Adult medulloblastoma (MB) is rare, accounting for 150–300 new cases in the US annually. Given the low incidence, prospective studies are challenging, and the role of adjuvant chemotherapy in standard risk patients has been controversial. Currently, the best evidence available (Level V)...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Mastall, M, Majd, N, Fuller, G, Gule-Monroe, M, Huse, J, Khatua, S, Rao, G, Sandberg, D, Wefel, J, Yeboa, D, Zaky, W, Mahajan, A, Puduvalli, V, Suki, D, Alfaro, K, Weathers, S, Harrison, R, de Groot, J, Penas-Prado, M
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Poster Presentations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144716/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.419
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料